NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000890

Registered date:22/11/2007

Japan Elderly Diabetes Intervention Study

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedDiabetes Mellitus in the Elderly
Date of first enrollment2001/03/01
Target sample size1500
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Intensive treatment group: HbA1c<6.5%, Blood preesure <130/85mmHg,Total cholesterol:<180mg/dl (If CHD is present), or <200mg/dl (If CHD is absent),Triglycerides<150mg/dl, HDL cholesterol>40mg/dl, and BMI<25. Conventional treatment group: goals as attending doctors consider to be proper. :at least fasting plasma glucose <200mg/dl or HbA1c<9.0%

Outcome(s)

Primary Outcome1.Fatal endpoints: diabetes-specific death including cardiovaslular death, and non-diabetes-specific death 2.Non-fatal endpoints: acute myocardial infarction, other IHDs, cerebrovascular disease, arterial peripheral vascular disease, diabetic gangrene, and the blindness due to diabetic retinopathy.
Secondary OutcomeDiabetic microangiopathy(reitinopathy, nephropathy,neuropathy), vitreous hemorrhage, congestive heart failure, and retinal photocoagulation.

Key inclusion & exclusion criteria

Age minimum65years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteriatype 1 diabetes acute disease malignancy

Related Information

Contact

public contact
Name Atsushi Araki
Address 35-2 Sakae-cho, Itabashi-ku, Tokyo173-0015, Japan Japan
Telephone 03-3964-1141
E-mail
Affiliation Tokyo Metropolitan Geriatric Hospital Division of Endocrinology
scientific contact
Name Hideki Ito
Address 35-2 Sakae-cho, Itabashi-ku, Tokyo173-0015, Japan Japan
Telephone 03-3964-1141
E-mail
Affiliation Tokyo Metropolitan Geriatric Hospital President